Log In
Print
BCIQ
Print
Print this Print this
 

TALL-104

  Manage Alerts
Collapse Summary General Information
Company Wistar Institute
DescriptionCytotoxic T cell line derived from a leukemia patient
Molecular Target Not available
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentPhase II
Standard IndicationOvarian cancer
Indication DetailsTreat peritoneal carcinosis due to ovarian cancer
Regulatory Designation

Partner

Abiogen Pharma S.p.A.; Galileo Research s.r.l.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today